Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Apr 1;4(2):e345.
doi: 10.1097/HS9.0000000000000345. eCollection 2020 Apr.

Allogeneic Hematopoietic Cell Transplantation in Patients With Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria Clones: Time for a Change

Eleni Gavriilaki  1 , Ioanna Sakellari  1 , Despina Mallouri  1 , Ioannis Batsis  1 , Thomas Chatziconstantinou  1 , Anna Vardi  1 , Zoi Bousiou  1 , Marianna Masmanidou  1 , Vassiliki Douka  1 , Antonia Syrigou  1 , Damianos Sotiropoulos  1 , Varnavas Constantinou  1 , Achilles Anagnostopoulos  1
Affiliations

Allogeneic Hematopoietic Cell Transplantation in Patients With Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria Clones: Time for a Change

Eleni Gavriilaki et al. Hemasphere. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

Figure 1
Figure 1
Overall survival is significantly lower in patients with PNH clones (p < 0.001). PNH: paroxysmal nocturnal hemoglobinuria.
See this image and copyright information in PMC

References

    1. Bacigalupo A. How I treat acquired aplastic anemia. Blood. 2017;129:1428–1436. - PubMed
    1. Lee JW, Peffault de Latour R, Brodsky RA, et al. Effectiveness of eculizumab in patients with paroxysmal nocturnal hemoglobinuria (PNH) with or without aplastic anemia in the International PNH Registry. Am J Hematol. 2019;94:E37–E41. - PubMed
    1. DeZern AE, Jones RJ, Brodsky RA. Eculizumab bridging before bone marrow transplant for marrow failure disorders is safe and does not limit engraftment. Biol Blood Marrow Transplant. 2018;24:e26–e30. - PMC - PubMed
    1. Mei M, Gupta R, O’Donnell M, et al. Post-allogeneic hematopoietic stem cell transplantation eculizumab as prophylaxis against hemolysis and thrombosis for patients with hematologic disorders associated with paroxysmal nocturnal hemoglobinuria clones. Biol Blood Marrow Transplant. 2019;25:e183–e185. - PubMed
    1. Cooper JP, Farah RJ, Stevenson PA, et al. Hematopoietic Cell Transplantation for Paroxysmal Nocturnal Hemoglobinuria in the Age of Eculizumab. Biol Blood Marrow Transplant. 2019;25:1331–1339. - PMC - PubMed